Characterization of a survival pathway controlled by FGFR4 in alveolar Rhabdomyosarcoma

被引：0
|
作者：
Wachtel, Marco
Schafer, Beat
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-3418
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3418
引用
收藏
页数：3
相关论文
共 50 条
  • [1] FGFR4 Pathway Mutations in Embryonal Type of Rhabdomyosarcoma
    Sato, Aiko
    Seki, Masafumi
    Shiraishi, Yuichi
    Chiba, Kenichi
    Tanaka, Hiroko
    Okita, Hajime
    Miyano, Satoru
    Ogawa, Seishi
    Hosoi, Hajime
    Takita, Junko
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S28 - S28
  • [2] PAX3-FOXO1 and FGFR4 in alveolar rhabdomyosarcoma
    Marshall, Amy D.
    van der Ent, Martijn A.
    Grosveld, Gerard C.
    MOLECULAR CARCINOGENESIS, 2012, 51 (10) : 807 - 815
  • [3] Characterization of a novel anti-apoptotic signaling pathway downstream of FGFR4 in rhabdomyosarcoma
    Wachtel, Marco
    Schaefer, Beat
    CANCER RESEARCH, 2011, 71
  • [4] FGFR4 AS A THERAPEUTIC TARGET IN HUMAN ALVEOLAR VERSUS EMBRYONAL RHABDOMYOSARCOMA
    Crose, Lisa
    Etheridge, Katherine
    Chen, Candy
    Bentley, Rex
    Linardic, Corinne
    PEDIATRIC BLOOD & CANCER, 2010, 54 (06) : 792 - 792
  • [5] Targeting FGFR4 for rhabdomyosarcoma immunotherapy
    Cheuk, A. T. C.
    Shivaprasad, N.
    Kumar, J.
    Azorsa, P.
    Skarzynski, M.
    Baskar, S.
    Orentas, R.
    Khan, J.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E9 - E10
  • [6] FGFR4 signaling couples to Bim and not Bmf to discriminate subsets of alveolar rhabdomyosarcoma cells
    Wachtel, Marco
    Rakic, Jelena
    Okoniewski, Michal
    Bode, Peter
    Niggli, Felix
    Schaefer, Beat W.
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (07) : 1543 - 1552
  • [7] FGFR4 Blockade Exerts Distinct Antitumorigenic Effects in Human Embryonal versus Alveolar Rhabdomyosarcoma
    Crose, Lisa E. S.
    Etheridge, Katherine T.
    Chen, Candy
    Belyea, Brian
    Talbot, Lindsay J.
    Bentley, Rex C.
    Linardic, Corinne M.
    CLINICAL CANCER RESEARCH, 2012, 18 (14) : 3780 - 3790
  • [8] TREATMENT STRATEGY FOR A GROUP OF POOR PROGNOSIS EMBRYONAL RHABDOMYOSARCOMA WITH ACTIVATION OF THE FGFR4 PATHWAY
    Isobe, Kiyotaka
    Sato, Aiko
    Uchihara, Yoshinori
    Tojo, Ryunosuke
    Tasaka, Keiji
    Mikami, Takashi
    Umeda, Katsutsugu
    Isobe, Tomoya
    Seki, Masafumi
    Takita, Junko
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S33 - S33
  • [9] Potent tumoricidal activity of a FGFR4 CART in rhabdomyosarcoma.
    Cheuk, Adam
    Tian, Meijie
    Kumar, Jeetendra
    Azorsa, Peter
    Shivaprasad, Nityashree
    Schneider, Dina
    Gryder, Berkley
    Wei, Jun
    Song, Young
    Wen, Xinyu
    Sindiri, Sivasish
    Chung, Joon-Yong
    Zhu, Zhongyu
    Dimitrov, Dimiter
    Hewitt, Stephen
    Dropulic, Boro
    Orentas, Rimas
    Khan, Javed
    CANCER RESEARCH, 2021, 81 (13)
  • [10] Targeting FGFR4 with monoclonal antibodies as therapeutic agents for the treatment of rhabdomyosarcoma
    Baskar, Sivasubramanian
    CANCER RESEARCH, 2016, 76
12345